The Absolute Count of Lymphocytes Is a Strong Predictive Factor for Relapse/Regrowth Events and Outcomes in Patients with Regressive Methotrexate-Associated Lymphoproliferative Disorders

MLA

Reiko Nakaseko, et al. “The Absolute Count of Lymphocytes Is a Strong Predictive Factor for Relapse/Regrowth Events and Outcomes in Patients with Regressive Methotrexate-Associated Lymphoproliferative Disorders.” Blood, vol. 132, Nov. 2018, p. 1589. EBSCOhost, https://doi.org/10.1182/blood-2018-99-114382.

APA

Reiko Nakaseko, Tomoe Anan-Nemoto, Tabayashi Takayuki, Morihiro Higashi, Tatsuki Tomikawa, Michihide Tokuhira, Yuka Tanaka, Yuta Kimura, Morihiko Sagawa, Junichi Watanabe, Yasuyuki Takahashi, Jun-ichi Tamaru, Shuji Momose, & Masahiro Kizaki. (2018). The Absolute Count of Lymphocytes Is a Strong Predictive Factor for Relapse/Regrowth Events and Outcomes in Patients with Regressive Methotrexate-Associated Lymphoproliferative Disorders. Blood, 132, 1589. https://doi.org/10.1182/blood-2018-99-114382

Chicago

Reiko Nakaseko, Tomoe Anan-Nemoto, Tabayashi Takayuki, Morihiro Higashi, Tatsuki Tomikawa, Michihide Tokuhira, Yuka Tanaka, et al. 2018. “The Absolute Count of Lymphocytes Is a Strong Predictive Factor for Relapse/Regrowth Events and Outcomes in Patients with Regressive Methotrexate-Associated Lymphoproliferative Disorders.” Blood 132 (November): 1589. doi:10.1182/blood-2018-99-114382.